Hypertension and Coronary Microvascular Disease

  • B. E. Strauer
  • B. Schwartzkopff
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 432)


Arterial hypertension represents the most frequent kind of left ventricular pressure overload in man. As former studies in our clinic have shown, three distinct types of left ventricular hypertrophy may occur: concentric — irregular — eccentric (1). The main functional features of these different types of hypertrophy imply: (I) Left ventricular systolic ejection fraction is normal, despite of significant or excessive increase in left ventricular muscle mass as long as ventricular volume is not increased. Diastolic function is impaired at all stages of LV hypertrophy. (II) There is an inverse relationship between systolic wall stress, i.e. left ventricular afterload, and left ventricular function. (Ill) Systolic wall stress is directly correlated with LV myocardial oxygen consumption. (IV) In hypertensive hypertrophy there is, even at normal coronary arteriogram, significant reduction in coronary reserve (2) (Fig. 1). Both, reduction in coronary reserve and diastolic dysfunction already may occur in the prehypertrophic state of hypertensive heart disease.


Diastolic Dysfunction Coronary Flow Reserve Hypertensive Heart Disease Coronary Resistance Coronary Reserve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Strauer BE: Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44: 999–1006PubMedCrossRefGoogle Scholar
  2. 2.
    Strauer BE: Coronary hemodynamics in hypertensive heart disease. Am J Med 1988; 84: 45–54PubMedCrossRefGoogle Scholar
  3. 3.
    Anversa P, Ricci R, Olivetti G: Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy. A review. J Am Coll Cardiol 1986; 7: 1140–1149PubMedCrossRefGoogle Scholar
  4. 4.
    Katz A: cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322: 100–110PubMedCrossRefGoogle Scholar
  5. 5.
    Nadal-Ginard B, Mahdavi V: Molecular mechanisms of cardiac gene expression, pp 65–80. In: Strauer BE (ed): The heart in Hypertension. Springer-Verlag, New York 1993Google Scholar
  6. 6.
    Capasso JM, Palackal T, Olivetti G, Anversa P: Left ventricular failure — induced by long-term hypertension in rats. Circ Res 1990; 66: 1400–1412PubMedCrossRefGoogle Scholar
  7. 7.
    Weber KT, Sun Y, Guarda E: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994; 23: 869–877PubMedCrossRefGoogle Scholar
  8. 8.
    Schwartzkopff B, Motz W, Knauer S, Frenzel H, Strauer BE: Morphometric investigations of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy. J cardiovasc Pharmacol, Suppl 1 1992; 20: 12–17Google Scholar
  9. 9.
    Tillmanns H, Steinhausen M, Leinberger H, Thederau H, Kubier W: Pressure measurement in the terminal vascular bed of the epicardium of rats and cats. Cir Res 1981; 49: 1202–1211CrossRefGoogle Scholar
  10. 10.
    Mulvany MJ: Vascular growth in hypertension. J Cardiovasc Pharmacol 1992; 22: 7–11Google Scholar
  11. 11.
    Opherk D, Mall G, Zebe H et al: Reduction of coronary reserve. A mechanism for angina pectoris in patients with arterial hypertension and normal arteries. Circulation 1984; 69: 1–7PubMedCrossRefGoogle Scholar
  12. 12.
    Schwartzkopff B, Motz W, Frenzel H et al.: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993–1003PubMedCrossRefGoogle Scholar
  13. 13.
    Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72: 369–417PubMedGoogle Scholar
  14. 14.
    Moritz AR, Oldt MR: Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937; 13:679–728PubMedGoogle Scholar
  15. 15.
    Dzau VJ, Gibbons GH, Cooke JP, Omoigui N: Vascular biology and medicine in the 1990s. Scope, concepts, potentials and perspectives. Circulation 1993; 87: 705–719PubMedCrossRefGoogle Scholar
  16. 16.
    Scott-Burden T, Resink TJ, Baur U, Bürgin M, Bühler FR: Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension 1989; 13: 295–304PubMedCrossRefGoogle Scholar
  17. 17.
    James JN: Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol 1990; 65: 12G-22GCrossRefGoogle Scholar
  18. 18.
    Schwartzkopff B, Frenzel H, Dieckerhoff J et al.: Morphometric investigation of humen myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J, Suppl D 1992; 13: 17–20PubMedCrossRefGoogle Scholar
  19. 19.
    Schwartzkopff B, Motz W, Strauer BE: Repair of human myocardial structure by chronic treatment with ACE-inhibitors in hypertensive heart disease. Circulation Suppl. I 1994; 90: 343Google Scholar
  20. 20.
    Diez J, Laviades C, Mayor G, Gil MJ, Monreal I: Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450–1456PubMedCrossRefGoogle Scholar
  21. 21.
    Motz W, Vogt M, Scheler S et al.: Prophylaxe mit gefäßaktiven Substanzen. Z Kardiol, Suppl. 4 1992; 81: 199–204PubMedGoogle Scholar
  22. 22.
    Motz W, Strauer BE: Improvement of coronary flow reserve after long-term therapy with Enalapril. Hypertension 1996; 27: 1031–1058PubMedCrossRefGoogle Scholar
  23. 23.
    Vogt M, Motz W, Strauer BE: Antihypertensive Langzeittherapie mit Isradipin. Arzneimittel Forschung; 44: 1321–1318Google Scholar
  24. 24.
    Motz W, Vogt M, Scheler S, Schwartzkopff B, Strauer BE: Verbesserung der Koronarreserve nach Hypertrophieregression durch antihypertensive Therapie mit einem Beta-Rezeptorenblocker. Dtsch Med Wochenschr 1993; 118: 540–553CrossRefGoogle Scholar
  25. 25.
    Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771–1779PubMedCrossRefGoogle Scholar
  26. 26.
    Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83–91PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • B. E. Strauer
    • 1
  • B. Schwartzkopff
    • 1
  1. 1.Med. Klinik and Policlinic BHeinrich Heine UniversityDüsseldorfGermany

Personalised recommendations